Toll Biotech Co., Ltd.(Beijing) Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2020

Location

Beijing China

Primary Industry

Biotechnology

About

Established in 2020 and based in Beijing, China, Toll Biotech Co., Ltd.(Beijing) is a technology company that provides research and development of new drugs for autoimmune diseases. The founder of the company, Professor Yin Hang, is the Associate Dean, School of Pharmacy, Tsinghua University. The company also was awarded as Zhongguancun High-Tech Enterprises. The company has launched three technology platforms which are new drug development platform, preclinical development platform and clinical development platform. The company's product pipeline can be applied to rheumatoid arthritis, lupus erythematosus, viral infections, Parkinson's, etc. The company has cooperation with Tsinghua University, Peking University, Chinese Academy of Sciences and etc. The company will focus on the development of new drugs for autoimmune diseases and the construction of the company's research and development center and drug development platform to further strengthen the company's research and development strength and expand its pipeline.

Current Investors

Lotus Lake Capital, Zhongguancun Development Group, Casstar Capital

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Healthcare Specialists

Website

www.toll-biotech.com

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.